We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.03%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$10.6B
AUM Growth
+$1.17B
Cap. Flow
+$3.01B
Cap. Flow %
28.27%
Top 10 Hldgs %
22.3%
Holding
850
New
52
Increased
273
Reduced
342
Closed
48

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$96.9M
2
MRK icon
Merck
MRK
+$73.5M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.1M
4
ILMN icon
Illumina
ILMN
+$40.4M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$57.2M
2
IMMU
Immunomedics Inc
IMMU
+$51.7M
3
KMB icon
Kimberly-Clark
KMB
+$28.5M
4
BPMC
Blueprint Medicines
BPMC
+$26.5M
5
ANET icon
Arista Networks
ANET
+$22.7M

Sector Composition

Rank Sector Weight
1 Healthcare 35.77%
2 Technology 20.35%
3 Consumer Discretionary 9.49%
4 Communication Services 7.69%
5 Financials 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TU icon
351
Telus
TU
$14.6B
$4.84M 0.05%
276,066
+113,669
+70% +$2.02M
PVLA
352
Palvella Therapeutics
PVLA
$2.02B
$4.78M 0.04%
28,848
-470
-2% -$107K
LRCX icon
353
Lam Research
LRCX
$378B
$4.76M 0.04%
143,420
-168,610
-54% -$5.81M
MSI icon
354
Motorola Solutions
MSI
$72.4B
$4.68M 0.04%
29,860
-295
-1% -$43.1K
UHS icon
355
Universal Health Services
UHS
$10.1B
$4.66M 0.04%
43,546
+13,945
+47% +$1.49M
CNI icon
356
Canadian National Railway
CNI
$77B
$4.64M 0.04%
43,702
-463
-1% -$46.5K
PLNT icon
357
Planet Fitness
PLNT
$4.37B
$4.63M 0.04%
75,133
+5,609
+8% +$323K
IBN icon
358
ICICI Bank
IBN
$108B
$4.59M 0.04%
466,777
+142,225
+44% +$1.42M
CNX icon
359
CNX Resources
CNX
$4.95B
$4.58M 0.04%
+485,285
New +$4.95M
ITW icon
360
Illinois Tool Works
ITW
$82.5B
$4.55M 0.04%
23,540
-1,590
-6% -$302K
PBA icon
361
Pembina Pipeline
PBA
$28.6B
$4.48M 0.04%
211,773
+16,804
+9% +$413K
CF icon
362
CF Industries
CF
$19.2B
$4.46M 0.04%
145,257
+92,054
+173% +$2.93M
DGX icon
363
Quest Diagnostics
DGX
$25.9B
$4.45M 0.04%
38,825
-2,008
-5% -$237K
D icon
364
Dominion Energy
D
$61.4B
$4.44M 0.04%
56,229
-4,548
-7% -$357K
AKCA
365
DELISTED
Akcea Therapeutics Inc
AKCA
$4.43M 0.04%
+244,395
New +$3.47M
CDW icon
366
CDW
CDW
$18.8B
$4.4M 0.04%
36,840
-45,946
-55% -$5.26M
CBMG
367
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
$4.32M 0.04%
+235,317
New +$3.96M
EPZM
368
DELISTED
Epizyme, Inc
EPZM
$4.31M 0.04%
361,152
+96,138
+36% +$1.29M
NSC icon
369
Norfolk Southern
NSC
$75.4B
$4.24M 0.04%
19,833
-2,193
-10% -$440K
VEEV icon
370
Veeva Systems
VEEV
$33B
$4.21M 0.04%
14,969
-447
-3% -$118K
CSX icon
371
CSX Corp
CSX
$93.3B
$4.19M 0.04%
161,811
-9,972
-6% -$246K
K
372
DELISTED
Kellanova
K
$4.17M 0.04%
68,793
+769
+1% +$48.8K
DFS
373
DELISTED
Discover Financial Services
DFS
$4.16M 0.04%
72,033
-51,164
-42% -$2.68M
SBAC icon
374
SBA Communications
SBAC
$18.9B
$4.16M 0.04%
13,069
-13,291
-50% -$4.06M
TSCO icon
375
Tractor Supply
TSCO
$16B
$4.06M 0.04%
141,590
-18,470
-12% -$531K
13 14
15
16 17

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Candriam SCA's Q3 2020 Portfolio in Review

As of Q3 2020, Candriam SCA held 850 positions worth $10.6B, up 12% from $9.47B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $3.01B of net new capital in Q3 2020, opening 52 new positions and adding to 273 existing holdings. Its largest new stake was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $57.2M trimmed.

  • Candriam SCA's largest Q3 2020 buy was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.
  • Candriam SCA added most to Amgen in Q3 2020, an estimated $96.9M increase.
  • Candriam SCA's biggest Q3 2020 reduction was Apple, cutting an estimated $57.2M.
  • Candriam SCA fully exited G1 Therapeutics, Inc. Common Stock in Q3 2020, selling an estimated $21.1M.
  • Candriam SCA's ten largest holdings make up 22% of its $10.6B portfolio in Q3 2020.
  • Candriam SCA opened 52 new positions and closed 48 in Q3 2020.
  • Candriam SCA's portfolio value rose 12% quarter-over-quarter to $10.6B.

Based on Candriam SCA's 13F filing for Q3 2020, filed 19 Oct 2020.